ClinicalTrials.Veeva

Menu

ACE and HLA Genotypes Predict Severity and Disease Progression in Danish Sarcoid Patients

University of Aarhus logo

University of Aarhus

Status

Completed

Conditions

Sarcoidosis

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Sarcoidosis is a multisystem granulomatous disease of unknown cause histologically characterized by noncaseating granulomas. Genetic factors affect disease course, which is highly variable and difficult to predict.

This study aims to evaluate the predictive value of ACE and HLA genotypes on disease severity and progression in Danish patients with sarcoidosis.

Enrollment

150 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosis of sarcoidosis
  • Signed informed consent

Exclusion criteria

  • Inability or unwillingness to adhere to the study
  • Inability to give informed consent

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems